Prescription Opioid Use and Risk for Major Depressive Disorder and Anxiety and Stress-Related Disorders

Abstract

The findings of this mendelian randomization analysis suggest evidence for potential causal associations between the genetic liability for increased prescription opioid use and the risk for MDD and ASRD. While replication studies are necessary, these findings may inform prevention and intervention strategies directed toward the opioid epidemic and depression.